Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Emmessar Biotech and Nutrition Ltd

Your Vote -

Buy

66.67%

Hold

16.67%

Sell

16.67%

66.67%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Emmessar Biotech and Nutrition Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Emmessar Biotech - Newspaper Add

    25 Apr 2025, 6:52PM Please refer attachment
  • Emmessar Biotech - Results For The Period Ended March 31, 2025

    24 Apr 2025, 3:43PM Please refer attachment
  • Emmessar Biotech - Board Meeting Outcome for Financial Results For The Period Ended March 31, 2025

    24 Apr 2025, 2:34PM Please refer attachment
  • Emmessar Biotech - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    17 Apr 2025, 7:32PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Emmessar Biotech - Board Meeting Intimation for Consideration Of Audited Financial Results For The Period Ended March 31, 202

    16 Apr 2025, 3:07PM Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 ,inter alia, to
  • Emmessar Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    11 Apr 2025, 2:03PM Please refer attachment
  • Emmessar Biotech has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    10 Apr 2025, 4:20PM As of March 2025, 59.53% is owned by Indian Promoters and 40.47% by Public. <p align=justify> Top five Promoters holding highest number of shares of E
  • Emmessar Biotech - Newspaper Add For Unaudited Financials For Quarter Ended December 31, 2024

    7 Feb 2025, 1:42PM please refer attachment
  • Emmessar Biotech - Integrated Filing (Financial)

    6 Feb 2025, 1:55PM Please refer attachment
  • Emmessar Biotech - Announcement under Regulation 30 (LODR)-Change in Management

    6 Feb 2025, 1:53PM Please refer attachment
  • Emmessar Biotech - Unaudited Financial Results For The Quarter Ended December 31, 2024

    6 Feb 2025, 1:50PM Please refer attachment
  • Emmessar Biotech - Board Meeting Outcome for For Unaudited Financial Results For The Quarter Ended December 31, 2024

    6 Feb 2025, 1:46PM Please refer attachment

Key fundamentals

Evaluate the intrinsic value of Emmessar Biotech and Nutrition Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 7.708 7.5118 6.7467 6.1689 5.7007
Liabilities 7.708 7.5118 6.7467 6.1689 5.7007
Equity 4.9961 4.9961 4.9961 4.9961 4.9961
Gross Profit -0.9524 -1.0819 -0.6902 -0.8948 0.8466
Net Profit 0.3161 0.7496 0.5038 0.4753 1.4497
Cash From Operating Activities 0.2238 0.6445 0.3762 2.2698 0.4678
NPM(%) 51.75 135.01 49.43 130.25 20.73
Revenue 0.6108 0.5552 1.0192 0.3649 6.9907
Expenses 1.5632 1.6371 1.7094 1.2598 6.1441
ROE(%) 4.1 9.72 6.53 6.16 18.8

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Emmessar Biotech and Nutrition Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 778.05 -0.18 41.79 31.80 910.25 0.77
Sharda Cropchem Ltd 546.75 -0.71 20.33 316.04 35.34 0.55
Ram Minerals and Chemicals Ltd 0.49 0.00 49.00 720.88 -0.09 0.00
Amines and Plasticizers Ltd 206.90 -2.82 27.85 192.74 361.94 0.24

Company Info

The Company was incorporated in the state of Maharashtra as a Public Limited Company on 17th March 1992 and certificate of commencement of business dt. 20.3.92 was obtained from Registrar of Companies, Maharashtra, Bombay. The Registered office of the Company is situated at Plot No. T-3/2, MIDC Area, P.O. Box No. 39, Taloja - 410 208, Raigad (Dist), Maharashtra. The Company has revalued the land admeasuring 16,126 Sq. meters, in the month of January 1994, since the MIDC rate per Sq. meter had increased to Rs. 550/- from Rs. 200/- at the time of its purchase in the month of October 1992. The value of the land is now recorded at Rs.88,71,300/- instead of Rs. 32,52,400/ - which was the cost price, vide the valuation report of D K Nagarseth & Associates( Approved Valuer No. F-2087) dated 4th, Jan., 1994. MAIN OBJECTS OF THE COMPANY The main objects to be pursued by the Company on its incorporation as stated in its Memorandum of Association are: To formulate, develop, manipulate, process, import, export, buy, sell, or otherwise deal in all Organic and Inorganic chemicals, Fine chemicals, Heavy chemicals, Performance chemicals, Agro-chemicals, all kinds of organic and Inorganic pigments, colour, Dyestuffs and their intermediates, all kinds of Organic and Inorganic acids and alkalies, Drugs, Medicines and their intermediates, Silicon and Phosphorus based chemicals and byproducts thereof and products to be made there from, and all tools of Bio- Technology. SUBSIDIARIES OF THE COMPANY The Company does not have any subsidiaries. 2005 -Emmessar Biotech enters into strategic alliance with Twilight Mercantiles 2007 -Emmessar Biotech has designated E-mail ID for Investor Complaints: investors@ebnl.in 2008 -Emmessar Technologies Private Ltd became Emmessar Technologies Ltd (ETL) -RESQ, an unfailing solution for treating all types of burns from heat & radiation was launched. -Cute N Comely, a premier topical application with protective & therapeutic properties to ensure an optimal & natural skin rejuvenation process was launched. 2009 -Frejomus tablets was launched to help mitigate joint pains that restrict movement for the middle and old aged people. 2010 -Sepecer, a reliable solution for neurological and physiological health for the middle ages and beyond was launched. 2011 -Psoribalm was launched to meet the long standing demand for a harmless & reliable treatment for the most obstinate & dangerous skin disease - Psoriasis. 2016 -Over 30 newly developed products to meet a spectrum of healthcare needs ready to be launched progressively from mid 2016 onwards.

The Company was incorporated in the state of Maharashtra as a Public Limited Company on 17th March 1992 and certificate of commencement of business dt. 20.3.92 was obtained from Registrar of Companies, Maharashtra, Bombay. The Registered office of the Company is situated at Plot No. T-3/2, MIDC Area, P.O. Box No. 39, Taloja - 410 208, Raigad (Dist), Maharashtra. The Company has revalued the land admeasuring 16,126 Sq. meters, in the month of January 1994, since the MIDC rate per Sq. meter had increased to Rs. 550/- from Rs. 200/- at the time of its purchase in the month of October 1992. The value of the land is now recorded at Rs.88,71,300/- instead of Rs. 32,52,400/ - which was the cost price, vide the valuation report of D K Nagarseth & Associates( Approved Valuer No. F-2087) dated 4th, Jan., 1994. MAIN OBJECTS OF THE COMPANY The main objects to be pursued by the Company on its incorporation as stated in its Memorandum of Association are: To formulate, develop, manipulate, process, import, export, buy, sell, or otherwise deal in all Organic and Inorganic chemicals, Fine chemicals, Heavy chemicals, Performance chemicals, Agro-chemicals, all kinds of organic and Inorganic pigments, colour, Dyestuffs and their intermediates, all kinds of Organic and Inorganic acids and alkalies, Drugs, Medicines and their intermediates, Silicon and Phosphorus based chemicals and byproducts thereof and products to be made there from, and all tools of Bio- Technology. SUBSIDIARIES OF THE COMPANY The Company does not have any subsidiaries. 2005 -Emmessar Biotech enters into strategic alliance with Twilight Mercantiles 2007 -Emmessar Biotech has designated E-mail ID for Investor Complaints: investors@ebnl.in 2008 -Emmessar Technologies Private Ltd became Emmessar Technologies Ltd (ETL) -RESQ, an unfailing solution for treating all types of burns from heat & radiation was launched. -Cute N Comely, a premier topical application with protective & therapeutic properties to ensure an optimal & natural skin rejuvenation process was launched. 2009 -Frejomus tablets was launched to help mitigate joint pains that restrict movement for the middle and old aged people. 2010 -Sepecer, a reliable solution for neurological and physiological health for the middle ages and beyond was launched. 2011 -Psoribalm was launched to meet the long standing demand for a harmless & reliable treatment for the most obstinate & dangerous skin disease - Psoriasis. 2016 -Over 30 newly developed products to meet a spectrum of healthcare needs ready to be launched progressively from mid 2016 onwards.

Read More

Parent Organisation

Emmessar Biotech & Nutrition Ltd.

Founded

17/03/1992

Managing Director

Mr.Srinivasa Raghavan Mathurakavi Ayyangar

NSE Symbol

FAQ

The current price of Emmessar Biotech and Nutrition Ltd is

The 52-week high for Emmessar Biotech and Nutrition Ltd is

The market capitalization of Emmessar Biotech and Nutrition Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Emmessar Biotech and Nutrition Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Emmessar Biotech and Nutrition Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Emmessar Biotech and Nutrition Ltd shares.

The CEO of Emmessar Biotech and Nutrition Ltd is Mr.Srinivasa Raghavan Mathurakavi Ayyangar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT